![]() | ![]() |
Formats:
|
||||||||||||||||||||||||
Copyright © 2008 The Author(s) Evolutionary origins of human apoptosis and genome-stability gene networks 1Bioinformatics Unit, Department of Biochemistry, Federal University of Rio Grande do Sul (UFRGS), Rua Ramiro Barcelos 2600-anexo, Porto Alegre 90035-003, 2Department of Biological Sciences, Lutheran University of Brazil, Gravataí 94170-240, 3Department of Physics, Federal University of Santa Maria (UFSM), Santa Maria 97105-900 and 4Institute of Physics, Federal University of Rio Grande do Sul (UFRGS), Avenida Bento Gonçalves 9500, Porto Alegre 91501-970, Caixa Postal 15051, Brazil Corresponding author.*To whom correspondence should be addressed. Tel: Phone: +55 51 3308 5577; Fax: +55 51 3308 5540; Email: mauro/at/ufrgs.br Correspondence may also be addressed to Rita M.C. de Almeida. Tel: +55 51 3308 6521; Fax: +55 51 3308 7286; Email: rita/at/if.ufrgs.br The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors. Received May 23, 2008; Revised September 14, 2008; Accepted September 15, 2008. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Apoptosis is essential for complex multicellular organisms and its failure is associated with genome instability and cancer. Interactions between apoptosis and genome-maintenance mechanisms have been extensively documented and include transactivation-independent and -dependent functions, in which the tumor-suppressor protein p53 works as a ‘molecular node’ in the DNA-damage response. Although apoptosis and genome stability have been identified as ancient pathways in eukaryote phylogeny, the biological evolution underlying the emergence of an integrated system remains largely unknown. Here, using computational methods, we reconstruct the evolutionary scenario that linked apoptosis with genome stability pathways in a functional human gene/protein association network. We found that the entanglement of DNA repair, chromosome stability and apoptosis gene networks appears with the caspase gene family and the antiapoptotic gene BCL2. Also, several critical nodes that entangle apoptosis and genome stability are cancer genes (e.g. ATM, BRCA1, BRCA2, MLH1, MSH2, MSH6 and TP53), although their orthologs have arisen in different points of evolution. Our results demonstrate how genome stability and apoptosis were co-opted during evolution recruiting genes that merge both systems. We also provide several examples to exploit this evolutionary platform, where we have judiciously extended information on gene essentiality inferred from model organisms to human. INTRODUCTION The concept of apoptosis is associated with the maintenance of tissue homeostasis (1). The programmed cell death (PCD) in the perspective of multicellular organisms guarantees the substitution of old and/or dysfunctional cells, which are impaired by the accumulation of cellular damages due to environmental insults, as well as participates directly in tissue development (2). According to KEGG (3), a reference pathway database, there are up to 100 genes coordinately working in apoptosis. Removing one of these components affects several others and it may impair the whole pathway. In complex metazoan organisms, a defective apoptosis is associated with organogenesis disorders and also uncontrolled cell growth, which is typically found in neoplastic diseases (4). In the perspective of a cancer cell, suppressed apoptosis is a requirement in order to enhance cell fitness (5). In some extent, it is thought that apoptosis is related to genome instability in the sense that mutation prone clones, containing aberrant genetic content (i.e. high number of chromosome aberrations and DNA point-mutations), need a defective apoptosis to escape cell death (6–8). Genome-maintenance mechanisms are intimately linked to apoptotic components, as indicates the high number of proteins that interact with the tumor-suppressor protein p53. In fact, this protein interacts with the four major DNA repair mechanisms: nucleotide excision repair (NER), base excision repair (BER), mismatch repair (MMR) and recombinational repair (RER)—homologous recombinational repair (HRR) and nonhomologous end-joining (NHEJ). Concerning NER and MMR, p53 can act in both transactivation-independent and -dependent manner (9). Furthermore, several DNA repair proteins can stimulate apoptosis in response to DNA lesions, as for example the BER-associated protein poly(ADP-ribose) polymerase-1 (PARP1) (10) and the MMR proteins MSH2, MSH6 and MLH1 (11). Indeed, the overlapping among apoptosis and DNA repair genes renders difficult a precise definition of functional boundaries among all systems, which is a characteristic of complex biological networks (12). On the other hand, apoptosis and genome-stability networks have different evolutionary roots. For instance, the core machinery of eukaryotic repair systems seems to be conserved among the three domains of life, although an expressive number of eukaryotic proteins have no counterpart in archaea or bacteria (13). Likewise, metazoan apoptosis contains several components that can be identified in ancient organisms such as prokaryotes and unicellular eukaryotes. However, many molecular sources in the eukaryotic apoptosis network might have been inherited from prokaryotes by horizontal gene transfer (HGT) in different events, being exapted to new functions to form apoptosis network (14). Notwithstanding the components of these two networks having been extensively identified in eukaryote phylogeny (15,16), few data are available about the evolutionary scenario that functionally linked apoptosis to genome-stability gene network (5,17,18). One approach to assess the role of each component in a given interacting network is through comparative genomics. Using well-studied models, as yeast and mouse, comparative genomics provides powerful tools to draw evolutionary inferences for poorly studied organisms (16). In a previous paper we characterized the entanglement among apoptosis and genome-stability pathways in a human protein–protein-association network (19). Here, we extend this characterization to build a platform to transfer functional information from several organisms to human. The idea is based on the consensus that each component of a gene/protein interaction network in the present living organisms has its origin at some point of the evolution. Thus the scenario that gives rise to the present network can be tracked-down by searching the root of each component in a given species tree. Our goal here is to create an orthology map across a species tree for the human apoptosis and genome-stability gene/protein-association network in order to transfer to humans the information described for other eukaryotes. We searched for orthologs [i.e. homologous genes derived from a single ancestral gene in the last common ancestor (LCA) of compared species (20)] among 35 fully sequenced eukaryotic genomes. Likely orthology was inferred from orthologous groups using STRING database (21,22), and for each set of orthologs we found the most parsimonious scenario on the eukaryote phylogeny (23). To verify this orthology data, we reconstructed the entire analysis using Inparanoid database as a different data source, and essentially obtained the same results (see Supplementary materials). As further network characterizations, we estimated gene plasticity by measuring gene abundance and distribution of each orthologous groups among the extant species, and considered essentiality data available for yeast and mouse orthologs. Both plasticity and essentiality information were transferred to the human gene network. As a result we obtained a gene network where it is possible to discriminate ancient, less plastic and more essential regions from earlier, more plastic and less essential ones. Furthermore, the many cancer genes identified in this gene network are located in the earlier, more plastic and less essential region. We anticipate that our analyses can be applied to study the origins of a broad range of neoplastic diseases. MATERIALS AND METHODS Human gene/protein-association network The protein–protein interaction network associating 180 human genes of apoptosis and genome-stability pathways has been extensively described in Ref. (19). Briefly, the network is generated using the database STRING (24) with input options ‘databases’,’experiments’ and 0.700 confidence level. STRING integrates different curated, public databases containing information on direct and indirect functional protein–protein associations. Each protein is identified according to both gene HUGO ID (25) and Ensembl Peptide ID (26) (Supplementary Table S1). The results from the search are saved in data files describing links between two genes and then handled in Medusa software (27). Parsimony analysis: inferring evolutionary roots of human apoptosis and genome-stability genes The parsimony analysis is divided into two major steps in order to construct parsimonious scenarios for individual sets of orthologous, given a species tree. We first built a consensus phylogeny for the eukaryotes listed in STRING database (22). The eukaryote phylogeny is based on a manual integration of a variety of phylogenies (28–33). We determined the presence of homologs among the organisms in the species tree for the 180 genes of apoptosis and genome-stability networks. Likely homology was inferred using the orthology information from the eukaryotic clusters of orthologous groups of proteins (KOGs) (21), which was retrieved through the orthology assignments in the STRING server; STRING has augmented the KOG orthology information by adding additional species (currently 35 eukaryotes) and creating more groups (NOGs, nonsupervised orthologous groups) as well as giving direct association among the three-domain phylogeny. In total, 142 eukaryotic orthologous groups were identified (Supplementary Table S1). To benchmark the analysis, we retrieved the orthologous groups for same set of genes using Inparanoid database, as discussed later. The second major step is the reconstruction of the evolutionary scenario for each individual set of orthologous genes. This problem has been previously formulated as follows (23): given a species tree and a set of orthologs with a particular phyletic pattern, find the most parsimonious mapping for the set of orthologs on the tree. Precisely, concerning our problem, this question can be restated as: for each orthologous group associated with the human apoptosis and genome-stability genes, find its earliest ortholog in the eukaryote phylogeny. The incongruence of any evolutionary scenario is resolved according to the gain/penalty approach (23), where the most parsimonious scenario of presence/absence of all the genes at all ancestral nodes of the tree is obtained by using an inconsistency function defined as
To verify the robustness of our orthology analysis we compared each gene evolutionary scenario with a corresponding one obtained using a different data source. In this case, we reconstructed the entire evolutionary analysis considering the Inparanoid database (39). In contrast to KOG algorithm, Inparanoid is designed to find orthologs and in-paralogs between two species and to separate in-paralogs from out-paralogs. KOG and Inparanoid orthology analysis lead to roughly the same conclusions. We present and discuss these results in Supplementary Material Online (Supplementary Figures S3–S6, S50–S94 and Table S4). Diversity analysis of orthologous groups An orthologous group (OG) corresponds to a set of genes from different extant species that have a common gene ancestor. To obtain a quantitative expression of the orthologous distribution (i.e. distribution of the items of an orthologous group), we have measured the information content of two different databases (STRING and Inparanoid) using Shannon Information Theory (7,40–43) defined as follows. Consider n as the number of selected OGs, each one representing an orthologous groups. Each OG is labeled by α (α = 1, …, n) and has Nα items (orthologous genes), distributed among M possible organisms. Consequently, for a given OG we can define s(i,α) as being the number of items of a given organism i, (i = 1, …, M), whose sum for a given α adds up to Nα The probability p(i,α) that, among the Nα items of the α-OG, a randomly chosen one belongs to the organism i is written as
Transference of functional information from yeast and mouse to human gene/protein-association network To predict developmental essentiality of a human gene, we used the mammalian phenotype information of the corresponding mouse orthologs. In this analysis, a gene is defined as ‘essential’ for organism development if a knock-out of a mouse ortholog confers embryonic or perinatal lethality (44). We obtained the mouse phenotype data from the curated knock-out collection available in Mouse Genome Database (MGD) (http://www.informatics.jax.org) (45). To predict cellular essentiality of a human gene, we used the phenotype information of the corresponding yeast orthologs. In this analysis, a human gene is defined as ‘essential’ at cellular level if a knock-out of its ortholog confers lethality to yeast. The yeast knock-out data were obtained from the Saccharomyces SGD project ‘Saccharomyces Genome Database’ (http://www.yeastgenome.org/) (46). Human and yeast orthology is also verified using as data source the Inparanoid database (47) and is provided in Supplementary Table S1. In this analysis, six essential genes, out of 32, were not listed as orthologs when using Inparanoid (these genes are presented in Figure 5
Human gene mutation statistics The data for the analysis of CAN genes is obtained from Cancer Gene Census (48). Both germline-mutated and somatic-mutated CAN genes are retrieved and then crossed with the list of 180 genes of our study. We identified 25 CAN genes placed in our network-based model of apoptosis and genome stability (Supplementary Table S1). Genotype statistics of germline CAN genes located on ρ module is further analyzed in the XP mutation database (http://www.xpmutations.org). The representativeness of the sample was tested against a second database [Human gene Mutation Database—HGMD (49)] which is regarded as a reference mutation database for (published) gene lesions responsible for human inherited diseases. Table 1 shows as equivalent the samples obtained here from HGMD and XP database. However, the former contains limited gene information comparing to the latter (50). Indeed, we could successfully retrieve the zygosity information only accessing the XP database.
RESULTS Apoptosis and genome-stability gene set Our analysis begins with a list of 180 genes participating in human apoptosis and genome-stability functions as previously defined (19) and provided as supplementary material online (Supplementary Table S1). To define this gene set we have characterized several genome-maintenance mechanisms as well as the interactions among their components. In Figure 1
Construction of parsimonious evolutionary scenarios In order to infer the ancestral states of human apoptosis and genome-stability genes we considered eukaryotic clusters of orthologous groups of proteins (KOGs) (21), using the orthology assignments in the STRING server (22). In total, apoptosis and genome-stability genes are distributed in 142 KOGs and for each one of these orthologous groups we found the most parsimonious mapping onto the eukaryote phylogeny. In Figure 2
To give a quantitative view of the evolutionary roots inferred for the 180 human genes studied here, we plotted the number of human apoptotic and genome-stability orthologs in each STN (Figure 2 In order to test a phylogeny where Caenorhabditis elegans is not at the root of the metazoa we included Nematostella vectensis, which thus changes the base of metazoa (Supplementary Figure S9). We chose this organism because (i) Nematostella is a cnidarian; (ii) the idea that the cnidarians are at the base of metazoa is less controversial than the nematodes; and (iii) switching a taxon like this goes some way to testing the effect of the phylogeny used. The result after this process is that the roots of the human genes remain almost the same (the complete analysis is available at Supplementary Table S5) and further discussed at supplements (section 1.4: the deep root of metazoans). From species-tree nodes to gene-network nodes To assess the details of the evolutionary scenario described earlier in the context of known and predicted gene functions, we used the network-based model presented in Figure 1 Starting from the complete network graph we generated three relevant orthology projections to characterize the functional differences between apoptosis and genome stability (Figure 3
The orthology information regarding other STNs is provided in Supplementary Table S1. As quantitatively showed in Figures 2 To analyze this result it is important to consider the biochemical signature of apoptosis, that is, the caspase activation, which is triggered by either intrinsic or extrinsic apoptosis pathways. The intrinsic pathway is associated with mitochondrial outer membrane permeabilization and cytochrome c (CYCS) release in response primarily to developmental cues or cellular damage. It triggers apoptosis through the Bcl-2 gene family and the initiator protease caspase-9. In contrast, the extrinsic pathway is characterized by the ligation of cell surface receptors via specific death ligands, as the TNF gene product, to generate catalytically active caspase-8 (51,52). The protein encoded by TNF gene is a multifunctional proinflammatory cytokine that belongs to the tumor necrosis factor (TNF) superfamily, which also includes the ligands FAS (FASLG) and TRAIL (TNFSF10). These ligands bind to several members of TNF-receptor superfamily (e.g. TNFRSF1A, TNFRSF10A, TNFRSF10B and FAS receptors) and are involved in the regulation of a wide spectrum of biological processes, such as immune surveillance, innate immunity, haematopoiesis and tumor regression [for review, see (53)]. Accordingly, it is noticeable that the components of intrinsic pathway are rooted mainly in STN-L or earlier (e.g. CYCS is deeply rooted in eukaryote species tree—Figure 3 In STN-P projection (Figure 3 Taking all results together, this evolutionary scenario of genome-maintenance mechanisms is marked by three major functional increments: the first is the evolution of genome-stability gene network, whose components originate in the basal position of this species tree [STN-P, inconsistency between datasets R = 0.63 STNs ±0.22 (SE)]; the second is the appearance of several apoptotic intrinsic components, rooted near metazoan divergence [STN-L, inconsistency between datasets R = 1.23 STNs ±0.23 (SE)]; the third consists of the network enrichment with several apoptotic extrinsic members and happens near chordate-vertebrata root [STN-I, inconsistency between datasets R = 0.35 STNs ±0.16 (SE)]. The network core of apoptosis and genome-stability systems are rooted in this tree before the divergence of metazoans, while GNNs placed in the periphery of the networks represent more recent evolutionary innovations. Therefore, the striking feature of these graphs is the increasing association between apoptosis and genome-stability functions with the emergence of an entangled gene network, which is fully consistent with the evolutionary strategy used in eukarya of adding complexity to existing core systems (54,55). (Inparanoid database essentially produces the same evolutionary scenario; please see Supplementary Figure S6.) Also, additional evidence of the ancestral roots of genome stability can be inferred considering the likely origin of the ancestral eukaryotic KOGs by identifying their closest prokaryotic orthologous groups (COGs). The KOG-to-COG correspondence is presented in Supplementary Figure S8, and shows that 77.0% of the genome-stability orthologs have identifiable prokaryotic orthologous groups, against 39.5% for apoptotic orthologous genes. Despite the several organisms that have been considered, the construction of the gene network is directed to human. Therefore, the interpretation of the evolutionary scenarios is ultimately linked with the characterization the human gene network. It means that we cannot infer that the gene network in the actual organism at the root of the eukaryotes was smaller. As we have stated in the introduction section, our goal is to create an orthology map across the species tree in order to transfer to human the information described for other eukaryotes. This is a one-way strategy, which is explored in the subsequent sections. Plasticity analysis Genetic plasticity may be understood as the ability of a functional gene network to tolerate changes in its components. There are different sources for such changes (gene duplication, gene loss, mutations and horizontal gene transfers), with different causes and effects. These changes in the genome may or may not be naturally selected, depending on the effect they have either on cell fitness or organism viability, in the case of complex organisms. The result of such an evolutionary dynamics is genetic variability among organisms of the same species or, ultimately, speciation. Gene networks are not equally plastic and hence do not equally respond to these variation pressures: depending on the gene, its function, influence on other genes, and their relevance, some changes are more likely to be tolerated or selected than others. Focusing in networks in general, one may expect that gene networks that are more tolerant to variation will present a larger variability inside a species and among species. Focusing now on individual genes, organisms should be more tolerant to drastic changes (e.g. gene knock-out) when the change is performed on genes located at a more plastic network. These two characteristics, the gene variability among different genomes and the organism response to knock-out of single genes, allow two independent measures to estimate gene network plasticity. One possible plasticity measure is estimating the number and the distribution of orthologs among different organisms. A second, independent plasticity measure may be obtained by assessing cell lethality data. In what follows we present and discuss these two plasticity measures. Diversity and abundance analysis We evaluated the diversity and abundance of the orthologous groups to estimate the plasticity of each gene in our human apoptosis and genome-stability gene network (precise definition in the Materials and methods section and further exemplified in Supplementary Material Online). The network graph presented in Figure 4
Observe that this inhomogeneous distribution of white, red and black GNNs in the network graph reflects also in the function performed by the genes. While white and red GNNs are clearly populating apoptosis network, black GNNs are placed mainly in genome stability. This result suggests a high evolutionary conservation of genome-stability orthologs (i.e. class b, orthologs present in many organisms and with few variants), contrasting with apoptosis GNNs that concentrate the plasticity of the network (i.e. class c orthologs with many variants per organisms). Essentiality in Saccharomyces cerevisiae A second, independent plasticity measure is obtained by assessing cell lethality data. Here we considered the eukaryotic model Saccharomyces cerevisiae available in the Saccharomyces Genome Database (SGD) (46). We transferred this information to the STN representing the LCA of yeast and human (i.e. STN-M), which is then projected on the corresponding human network topology. The yeast results are showed in Figure 5 Lethality in Mus musculus In order to complement this lethality measure with a complex multicellular eukaryotic model, we assessed Mus musculus lethality data in Mouse Genome Database—MGD (45). The phenotypic statistics in MGD database consider lethal any allele that causes death anytime after fertilization and before the postnatal day 2; thus, knock-out alleles may indicate ‘developmental lethality’ or ‘essentiality’ to embryonic stem cells. Evidence of mouse lethality is obtained according to the frequency expected by Mendelian genetics (i.e. zygosity and allelic distribution observed in the offspring): any significant deviation from the expected frequency for the knock-out allele indicates lethality. Therefore, from the putative 178 Mus musculus orthologs identified in our analysis, we find 124 genes for which knock-out data are available (Supplementary Table S1). While the majority produced viable phenotypes, 39 knock-out alleles have been associated with embryonic-perinatal lethality. The data are then transferred to the STN representing the LCA of mouse and human (i.e. STN-C) and then projected on the corresponding human network topology (Figure 5 Correlating plasticity and cancer statistics The most systematical, available data about the functional impairment of human genome-maintenance mechanisms comes from cancer statistics. According to a global human disease network described by Goh et al. (44), from the 180 genes listed in our genome-maintenance gene network, 51 are associated with some human disorder. From these, >50% are implicated in cancer. As an application for the plasticity estimates presented in the previous sections, we now consider cancer statistics data. Genes causally implicated in cancer are collectively identified as cancer genes—CAN genes (48), and share a common feature: while they are potentially lethal to organism due to disruption of tissue architecture, mutations in these genes that lead to cancer are not lethal to the cell. These mutations are of two types: somatic or germline. While the first arise after organism development and in few cells, the second are inherited—present before conception—and thus continue afterwards in every cell. In fact, germline mutations in CAN genes cause cancer predisposition, not cancer per se, contrasting with somatic mutations that are to a large extent the primary cause of cancers (56). Mutations that lead to cancer increase cell fitness (5,57), implying that the gene network may tolerate (and the cell may even benefit from) this genetic change (58). Consequently it is reasonable to expect that CAN genes are located on plastic gene networks. We assessed the cancer statistics available in the Cancer Gene Census at the Cancer Genome Project—CGP (http://www.sanger.ac.uk/genetics/CGP). The graph of Figure 5 The location of the germline mutations poses a challenge to our evolutionary scenario. How can we explain germline mutations in these human genes, given that they are located at a poorly plastic region? Also, care should be taken in order to consider these results together with yeast and mouse due to differences among statistical data. For instance, CAN gene statistics comes mainly from epidemiological data and shows exclusively genes in which mutations that are causally implicated in oncogenesis have been described at least in two independent reports, showing mutations in primary patient material (48). According to CGP census, the underlying rationale for interpreting a mutated gene as causal in cancer development is that the number and pattern of mutations in the gene are likely to have been selected because they confer a growth advantage on the cell population from which the cancer has developed (48). Also, in contrast to mouse and yeast knock-out alleles, CAN gene may have a range of mutations, from a single nucleotide substitution to a complete transcript disruption (i.e. null alleles is the most severe situation, equivalent to mouse and yeast knock-out data). In order to circumvent such data limitations and improve the analysis we further investigated the human statistics assessing the genotypic profile of several CAN gene loci. We attempt to obtain the proportion of null and non-null alleles in human following the strategy used in mouse to infer lethality according to the expected frequency in a Mendelian distribution. We focus the analysis in the set of CAN genes placed in ρ module, collectively represented in the same locus-specific mutation database—XP mutation database (http://www.xpmutations.org). These CAN genes are also associated with the same DNA repair function (nucleotide-excision repair) and are related to three rare autosomal recessive human clinical disorders (Xeroderma pigmentosum, Cockayne Syndrome and Trichothiodystrophy), which may turns reliable the obtaining of a representative sample (XP database is a repository of XP mutations identified in patients worldwide). We retrieved 182 mutated genotypes available in that database, which is then pooled according to the zygosity and the presence of null and nonnull alleles (Table 1, Panel A). Sample number is also compared to a second database in order to attest the representativeness of the database (Table 1, Panel B) (see Supplementary Material Online for further details). Given the data, in case null/null patients exist in some extent in human population, it would be a strong argument against the essentiality of genes located at the poorly plastic region of the network. As is pointed in Table 1, this is not the case. There is a total absence of null alleles in homozygous. Therefore, considering equivalent criteria among human, mouse and yeast to infer lethality, the data is consistent with lethality of germline CAN genes in the network projection, allowing the less-plastic area to be regarded as essential in human. DISCUSSION We presented an orthology map in order to locate the eukaryotic genes in the human apoptosis and genome-stability gene/protein-association network. According to our scenario, apoptosis and genome stability have different origins in the evolution, in spite of the complex interaction between both systems observed in human gene network (see Figure 6
Our results are consistent with several scenarios described by different authors. For instance, the position of genome stability in the base of eukaryotic species tree is highly consistence with the DNA repair functions described in prokaryotes [DNA repair in Escherichia coli is extensively recognized and has served as a paradigm for the investigation of other organisms: NER (59), BER (60), MMR (61) and RER (62)]. Also, the root of BCL2 in the base of LCA of metazoans is consistent with the identified pro-survival functioning of Bcl-2 protein family members in C. elegans (63,64). Likewise, the position of caspases and in the base of LCA of metazoans has been previously described (14), which is consistent with the origins of intrinsic pathway components that predate TNF-like cytokines (65). These TNF extrinsic pathway core components has been described across vertebrates (47) and corroborate our scenario, in line with the mammalian-like functioning of extrinsic apoptosis pathway described in Danio rerio and the absence of TNF and TNF receptor superfamily members in C. elegans (52). However, the novelty here is that our results describe the genome-maintenance mechanisms as a whole, in a network-based model, to produce a unique evolutionary scenario. This point of view allows investigating the sequential events that led to the entanglement of apoptosis and genome-stability gene networks. In the course of human genome-maintenance network evolution, three major functional increments are remarkable as is summarized in Figure 6 Furthermore, as the macroevolutionary perspective of these conclusions must be considered together with the estimated evolutionary error (i.e. two species tree nodes up and down from the rooting point in the species tree), it is conceivable that some genes are actually not as recent as one might think. Nevertheless, our conclusions do point that in the course of human genome-maintenance gene network evolution there must have been a dramatic increase in the number of apoptotic components, contrasting with the early origin of genome-stability genes. We identified the expansion of apoptotic components in both KOG and Inparanoid-derived data. This numerical expansion of apoptotic components could be related to the origin of other cell functions. Such assumption may be illustrated by the TP53 appearance at the transition to later evolutionary scenarios: p53 protein regulates not only apoptosis, but it is also a key regulator of cellular senescence, defined as a permanent cell cycle arrest (66). Senescence is an alternative tumor suppressor mechanism, where damaged cells are prevented from dividing (67). If the senescence has functionally emerged with TP53 gene, this second tumor-suppressor mechanism may have relaxed the selective pressure on apoptosis, increasing its tolerance against nonadaptive processes (e.g. genetic drift, mutation and recombination) and favoring its evolution. Our results are consistent with the emergence of both major mechanisms of tumor control during metazoan evolution, although in what regards senescence more genes should be taken into account to draw a safe conclusion. Likewise, TP53 can exemplify the evolution of genome-stability gene network. Acting as a transcription factor, p53 protein is able to modulate all DNA-repair processes (9,68). Such DNA-repair gene response to p53 protein is in line with evidences showing that even conserved gene functions are subject to substantial evolution at the regulatory level (69). The plasticity analysis pointed the genes that during evolution suffered less duplication, such that they are poorly abundant and widely distributed among extant species. The results locate these more conserved genes mainly on the genome-stability network, which is also the more ancient portion of the network. In contrast, certain pairs of genes known to function together in human are placed in different distribution and abundance (e.g. ATM and BRCA1, MUS81 and EME1, PCNA and RPA1, RPA1 and RPA2—Figure 4 Lethality measures were performed in two complementary ways: one assessing knock-out data on yeast genes and the second regarding essentiality in mice. These two measures are complementary for the following reasons: yeast is a unicellular organism and lethality concerns only cell viability, while mouse is a multicellular animal, with a complex ontogeny. In this later case, a viable embryo implies survival after egg implantation and a relevant cell expansion. As a consequence, when an organism is labeled as viable, certainly the cell is viable and so is the organism. However, when the organism is not viable, the experimental procedure does not always discriminate whether the problem occurred at cell or at organism level. In summary, lethality data on unicellular organisms as yeast give sound information on what genes are essential for cell viability, while on multicellular organisms as mice the sound information is on what genes are not essential at cell level. Transferring cell essentiality information from mice and yeast to the human apoptosis and genome-stability gene network revealed that essential genes at cell level are mostly located at the more ancestral region of the network. The integration of the information on ancestrality, plasticity and essentiality poses challenging questions. We found that the more ancient, less plastic and more essential genes are located on the genome stability, while the apoptosis network comprises the more recent, more plastic and less essential genes. Genome stability is required to guarantee the information transference from a parental genome to its offspring and thus provides one of the essential ingredients for natural selection to act: memory. It is not surprising that genome-stability network is rooted as early as possible in the species tree. It is also reasonable that such a crucial function is performed by highly conserved genes, where gene duplication is not favored due to the high possibility of disrupting a very essential pathway, yielding a poorly plastic network. Ancestrality, plasticity and essentiality have been pointed as correlated features in typical prokaryotes (70). On the other hand, in multicellular organisms with a more complex ontogeny, such as Mus musculus, the available literature reports not having found these correlations (71,72). Here we find cell gene essentiality to be correlated with ancestrality and plasticity in both unicellular and complex multicellular organisms. The point is that here we discriminate cell lethality from organism lethality: by isolating data from essential genes for cell survival from essential genes for organism viability, the correlation between cell essentiality, ancestrality and plasticity emerges and follows the same trends as in unicellular organisms. A test for this putative evolutionary scenario for the human genome-maintenance network is given by the location of the human CAN genes. In more complex organisms natural selection acts at two different levels (organism fitness and cell fitness), what may stem conflicting selective pressures: while a fast proliferating cell clone is naturally selected in a unicellular organism, a fast proliferating cell clone in a complex organism may represent a tumor that may end up by killing the organism. In complex organisms, apoptosis and genome-stability networks work also as tissue-maintenance mechanisms, favoring natural selection acting at the organism level. As disruption of such a mechanism may favor natural selection acting at cell level, it stands to reason that many CAN genes are located at the plastic, less cell-essential region of the genome-maintenance network. Specifically, concerning human functional data, at least two questions emerge from the evolutionary analysis of cancer statistics: (i) why the distribution of CAN genes is polarized between the two major segments described in the evolutionary scenario? and (ii) why CAN genes implicated in both types of cancers (somatic and germline) overlap apoptosis and genome-stability networks? While additional work will be needed to fully characterize the relevance of these results, it is clear for us that this evolutionary perspective may bring further insights in understanding cancer and its origins. SUPPLEMENTARY DATA Supplementary Data are available at NAR Online. FUNDING Brazilian Agencies FAPERGS, CAPES and CNPq (grant 140947/2006-0, partially). Funding for open access charge: grant 40947/2006-0. Conflict of interest statement. None declared. [Supplementary Data]
ACKNOWLEDGEMENTS We thank D. Jung for technical assistance. We acknowledge STRING, Inparanoid, MGD, SGD, CGP and XP databases for providing public access to their data. REFERENCES 1. Danial NN, Korsmeyer SJ. Cell death: critical control points. Cell. 2004;116:205–219. [PubMed] 2. Lettre G, Hengartner MO. Developmental apoptosis in C. elegans: a complex CEDnario. Nat. Rev. Mol. Cell Biol. 2006;7:97–108. [PubMed] 3. Kanehisa M, Goto S, Hattori M, Aoki-Kinoshita KF, Itoh M, Kawashima S, Katayama T, Araki M, Hirakawa M. From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res. 2006;34:D354–D357. [PubMed] 4. Hipfner DR, Cohen SM. Connecting proliferation and apoptosis in development and disease. Nat. Rev. Mol. Cell Biol. 2004;5:805–815. [PubMed] 5. Crespi B, Summers K. Evolutionary biology of cancer. Trends Ecol. Evol. 2005;20:545–552. [PubMed] 6. Yan B, Wang H, Peng Y, Hu Y, Wang H, Zhang X, Chen Q, Bedford JS, Dewhirst MW, Li CY. A unique role of the DNA fragmentation factor in maintaining genomic stability. Proc. Natl Acad. Sci. USA. 2006;103:1504–1509. [PubMed] 7. Castro MAA, Onsten TGH, Moreira JCF, de Almeida RMC. Chromosome aberrations in solid tumors have a stochastic nature. Mutat. Res. 2006;600:150–164. [PubMed] 8. Zhivotovsky B, Kroemer G. Apoptosis and genomic instability. Nat. Rev. Mol. Cell Biol. 2004;5:752–762. [PubMed] 9. Sengupta S, Harris CC. p53: Traffic cop at the crossroads of DNA repair and recombination. Nat. Rev. Mol. Cell Biol. 2005;6:44–55. [PubMed] 10. Alano CC, Ying W, Swanson RA. Poly(ADP-ribose) polymerase-1-mediated cell death in astrocytes requires NAD+ depletion and mitochondrial permeability transition. J. Biol. Chem. 2004;279:18895–18902. [PubMed] 11. Duckett DR, Bronstein SM, Taya Y, Modrich P. hMutSalpha- and hMutLalpha-dependent phosphorylation of p53 in response to DNA methylator damage. Proc. Natl Acad. Sci. USA. 1999;96:12384–12388. [PubMed] 12. Barabasi AL, Oltvai ZN. Network biology: understanding the cell's functional organization. Nat. Rev. Genet. 2004;5:101–113. [PubMed] 13. Aravind L, Walker DR, Koonin EV. Conserved domains in DNA repair proteins and evolution of repair systems. Nucleic Acids Res. 1999;27:1223–1242. [PubMed] 14. Koonin EV, Aravind L. Origin and evolution of eukaryotic apoptosis: the bacterial connection. Cell Death Differ. 2002;9:394–404. [PubMed] 15. Lin Z, Kong H, Nei M, Ma H. Origins and evolution of the recA/RAD51 gene family: evidence for ancient gene duplication and endosymbiotic gene transfer. Proc. Natl Acad. Sci. USA. 2006;103:10328–10333. [PubMed] 16. Aravind L, Dixit VM, Koonin EV. Apoptotic molecular machinery: vastly increased complexity in vertebrates revealed by genome comparisons. Science. 2001;291:1279–1284. [PubMed] 17. Merlo LMF, Pepper JW, Reid BJ, Maley CC. Cancer as an evolutionary and ecological process. Nat. Rev. Cancer. 2006;6:924–935. [PubMed] 18. Greaves M. Darwinian medicine: a case for cancer. Nat. Rev. Cancer. 2007;7:213–221. [PubMed] 19. Castro MAA, Mombach JCM, de Almeida RMC, Moreira JCF. Impaired expression of NER gene network in sporadic solid tumors. Nucleic Acids Res. 2007;35:1859–1867. [PubMed] 20. Koonin EV. Orthologs, paralogs, and evolutionary genomics. Annu. Rev. Genet. 2005;39:309–338. [PubMed] 21. Tatusov R, Fedorova N, Jackson J, Jacobs A, Kiryutin B, Koonin E, Krylov D, Mazumder R, Mekhedov S, Nikolskaya A, et al. The COG database: an updated version includes eukaryotes. BMC Bioinformatics. 2003;4:41. [PubMed] 22. von Mering C, Jensen LJ, Kuhn M, Chaffron S, Doerks T, Kruger B, Snel B, Bork P. STRING 7–recent developments in the integration and prediction of protein interactions. Nucleic Acids Res. 2007;35:D358–D362. [PubMed] 23. Mirkin BG, Fenner TI, Galperin MY, Koonin EV. Algorithms for computing parsimonious evolutionary scenarios for genome evolution, the last universal common ancestor and dominance of horizontal gene transfer in the evolution of prokaryotes. BMC Evol. Biol. 2003;3:2. [PubMed] 24. von Mering C, Jensen LJ, Snel B, Hooper SD, Krupp M, Foglierini M, Jouffre N, Huynen MA, Bork P. STRING: known and predicted protein-protein associations, integrated and transferred across organisms. Nucleic Acids Res. 2005;33:D433–D437. [PubMed] 25. Wain HM, Lush MJ, Ducluzeau F, Khodiyar VK, Povey S. Genew: the Human Gene Nomenclature Database, 2004 updates. Nucleic Acids Res. 2004;32:D255–D257. [PubMed] 26. Birney E, Andrews D, Caccamo M, Chen Y, Clarke L, Coates G, Cox T, Cunningham F, Curwen V, Cutts T, et al. Ensembl 2006. Nucleic Acids Res. 2006;34:D556–D561. [PubMed] 27. Hooper SD, Bork P. Medusa: a simple tool for interaction graph analysis. Bioinformatics. 2005;21:4432–4433. [PubMed] 28. Ciccarelli FD, Doerks T, von Mering C, Creevey CJ, Snel B, Bork P. Toward automatic reconstruction of a highly resolved tree of life. Science. 2006;311:1283–1287. [PubMed] 29. Letunic I, Bork P. Interactive Tree Of Life (iTOL): an online tool for phylogenetic tree display and annotation. Bioinformatics. 2007;23:127–128. [PubMed] 30. Pennisi E. Drafting a tree. Science. 2003;300:1694. [PubMed] 31. Baldauf SL. The deep roots of eukaryotes. Science. 2003;300:1703–1706. [PubMed] 32. Katinka MD, Duprat S, Cornillot E, Metenier G, Thomarat F, Prensier G, Barbe V, Peyretaillade E, Brottier P, Wincker P, et al. Genome sequence and gene compaction of the eukaryote parasite Encephalitozoon cuniculi. Nature. 2001;414:450–453. [PubMed] 33. Delsuc F, Brinkmann H, Philippe H. Phylogenomics and the reconstruction of the tree of life. Nat. Rev. Genet. 2005;6:361–375. [PubMed] 34. Snel B, Bork P, Huynen MA. Genomes in flux: the evolution of archaeal and proteobacterial gene content. Genome Res. 2002;12:17–25. [PubMed] 35. Kunin V, Ouzounis CA. The balance of driving forces during genome evolution in prokaryotes. Genome Res. 2003;13:1589–1594. [PubMed] 36. Campillos M, von Mering C, Jensen LJ, Bork P. Identification and analysis of evolutionarily cohesive functional modules in protein networks. Genome Res. 2006;16:374–382. [PubMed] 37. Itoh M, Nacher J, Kuma Ki, Goto S, Kanehisa M. Evolutionary history and functional implications of protein domains and their combinations in eukaryotes. Genome Biol. 2007;8:R121. [PubMed] 38. Pal C, Papp B, Lercher MJ. Adaptive evolution of bacterial metabolic networks by horizontal gene transfer. Nat. Genet. 2005;37:1372–1375. [PubMed] 39. Remm M, Storm CEV, Sonnhammer ELL. Automatic clustering of orthologs and in-paralogs from pairwise species comparisons. J. Mol. Biol. 2001;314:1041–1052. [PubMed] 40. Shannon CE. A mathematical theory of communication. Bell Syst. Tech. J. 1948;27:379–423. 41. Kendal WS. The use of information theory to analyze genomic changes in neoplasia. Math. Biosci. 1990;100:143–159. [PubMed] 42. Castro MAA, Onsten TTG, de Almeida RMC, Moreira JCF. Profiling cytogenetic diversity with entropy-based karyotypic analysis. J. Theor. Biol. 2005;234:487–495. [PubMed] 43. Gatenby RA, Frieden BR. Information dynamics in carcinogenesis and tumor growth. Mutat. Res. 2004;568:259–273. [PubMed] 44. Goh KI, Cusick ME, Valle D, Childs B, Vidal M, Barabasi AL. The human disease network. Proc. Natl Acad. Sci. USA. 2007;104:8685–8690. [PubMed] 45. Eppig JT, Blake JA, Bult CJ, Kadin JA, Richardson JE, the Mouse Genome Database Group The mouse genome database (MGD): new features facilitating a model system. Nucleic Acids Res. 2007;35:D630–D637. [PubMed] 46. Hirschman JE, Balakrishnan R, Christie KR, Costanzo MC, Dwight SS, Engel SR, Fisk DG, Hong EL, Livstone MS, Nash R, et al. Genome Snapshot: a new resource at the Saccharomyces Genome Database (SGD) presenting an overview of the Saccharomyces cerevisiae genome. Nucleic Acids Res. 2006;34:D442–D445. [PubMed] 47. O’Brien KP, Remm M, Sonnhammer ELL. Inparanoid: a comprehensive database of eukaryotic orthologs. Nucleic Acids Res. 2005;33:D476–D480. [PubMed] 48. Futreal PA, Coin L, Marshall M, Down T, Hubbard T, Wooster R, Rahman N, Stratton MR. A census of human cancer genes. Nat. Rev. Cancer. 2004;4:177–183. [PubMed] 49. Stenson PD, Ball EV, Mort M, Phillips AD, Shiel JA, Thomas NST, Abeysinghe S, Krawczak M, Cooper DN. Human gene mutation database (HGMD (R)): 2003 update. Hum. Mutat. 2003;21:577–581. [PubMed] 50. Claustres M, Horaitis O, Vanevski M, Cotton RGH. Time for a unified system of mutation description and reporting: a review of locus-specific mutation databases. Genome Res. 2002;12:680–688. [PubMed] 51. Beere HM. Death versus survival: functional interaction between the apoptotic and stress-inducible heat shock protein pathways. J. Clin. Invest. 2005;115:2633–2639. [PubMed] 52. Eimon PM, Kratz E, Varfolomeev E, Hymowitz SG, Stern H, Zha J, Ashkenazi A. Delineation of the cell-extrinsic apoptosis pathway in the zebrafish. Cell Death Differ. 2006;13:1619–1630. [PubMed] 53. Aggarwal BB. Signalling pathways of the TNF superfamily: a double-edged sword. Nat. Rev. Immunol. 2003;3:745–756. [PubMed] 54. Best AA, Morrison HG, McArthur AG, Sogin ML, Olsen GJ. Evolution of eukaryotic transcription: Insights from the genome of Giardia lamblia. Genome Res. 2004;14:1537–1547. [PubMed] 55. Huettenbrenner S, Maier S, Leisser C, Polgar D, Strasser S, Grusch M, Krupitza G. The evolution of cell death programs as prerequisites of multicellularity. Mutat. Res. 2003;543:235–249. [PubMed] 56. Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat. Med. 2004;10:789–799. [PubMed] 57. Breivik J, Gaudernack G. Resolving the evolutionary paradox of genetic instability: a cost-benefit analysis of DNA repair in changing environments. FEBS Lett. 2004;563:7–12. [PubMed] 58. Mombach JC, Castro MA, Moreira JC, de Almeida RM. On the absence of mutations in nucleotide excision repair genes in sporadic solid tumors. Genet. Mol. Res. 2008;7:152–160. [PubMed] 59. Setlow RB, Carrier WL. Disappearance of thymine Dimers from DNA - error-correcting mechanism. Proc. Natl Acad. Sci. USA. 1964;51:226–231. [PubMed] 60. Helling RB. Selection of a mutant of Escherichia coli which has high mutation rates. J. Bacteriol. 1968;96:975–980. [PubMed] 61. Wildenberg J, Meselson M. Mismatch repair in heteroduplex DNA. Proc. Natl Acad. Sci. USA. 1975;72:2202–2206. [PubMed] 62. Willetts NS, Clark AJ. Characteristics of some multiply recombination-deficient strains of Escherichia coli. J. Bacteriol. 1969;100:231–239. [PubMed] 63. Puthalakath H, Strasser A. Keeping killers on a tight leash: transcriptional and posttranslational control of the pro-apoptotic activity of BH3-only proteins. Cell Death Differ. 2002;9:505–512. [PubMed] 64. Youle RJ, Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol. 2008;9:47–59. [PubMed] 65. Igaki T, Kanda H, Yamamoto-Goto Y, Kanuka H, Kuranaga E, Aigaki T, Miura M. Eiger, a TNF superfamily ligand that triggers the Drosophila JNK pathway. EMBO J. 2002;21:3009–3018. [PubMed] 66. Rodier F, Campisi J, Bhaumik D. Two faces of p53: aging and tumor suppression. Nucleic Acids Res. 2007;35:7475–7484. [PubMed] 67. Campisi J. Cancer and ageing: rival demons? Nat. Rev. Cancer. 2003;3:339–349. [PubMed] 68. Lavin MF, Gueven N. The complexity of p53 stabilization and activation. Cell Death Differ. 2006;13:941–950. [PubMed] 69. Lynch M. The evolution of genetic networks by non-adaptive processes. Nat. Rev. Genet. 2007;8:803–813. [PubMed] 70. Jordan IK, Rogozin IB, Wolf YI, Koonin EV. Essential genes are more evolutionarily conserved than are nonessential genes in bacteria. Genome Res. 2002;12:962–968. [PubMed] 71. Liao BY, Zhang JZ. Mouse duplicate genes are as essential as singletons. Trends Genet. 2007;23:378–381. [PubMed] 72. Liang H, Li WH. Gene essentiality, gene duplicability and protein connectivity in human and mouse. Trends Genet. 2007;23:375–378. [PubMed] 73. Harris JK, Kelley ST, Spiegelman GB, Pace NR. The genetic core of the universal ancestor. Genome Res. 2003:GR-6528.. |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||||||||
Cell. 2004 Jan 23; 116(2):205-19.
[Cell. 2004]Nat Rev Mol Cell Biol. 2006 Feb; 7(2):97-108.
[Nat Rev Mol Cell Biol. 2006]Nucleic Acids Res. 2006 Jan 1; 34(Database issue):D354-7.
[Nucleic Acids Res. 2006]Nat Rev Mol Cell Biol. 2004 Oct; 5(10):805-15.
[Nat Rev Mol Cell Biol. 2004]Trends Ecol Evol. 2005 Oct; 20(10):545-52.
[Trends Ecol Evol. 2005]Nat Rev Mol Cell Biol. 2005 Jan; 6(1):44-55.
[Nat Rev Mol Cell Biol. 2005]J Biol Chem. 2004 Apr 30; 279(18):18895-902.
[J Biol Chem. 2004]Proc Natl Acad Sci U S A. 1999 Oct 26; 96(22):12384-8.
[Proc Natl Acad Sci U S A. 1999]Nat Rev Genet. 2004 Feb; 5(2):101-13.
[Nat Rev Genet. 2004]Nucleic Acids Res. 1999 Mar 1; 27(5):1223-42.
[Nucleic Acids Res. 1999]Cell Death Differ. 2002 Apr; 9(4):394-404.
[Cell Death Differ. 2002]Proc Natl Acad Sci U S A. 2006 Jul 5; 103(27):10328-33.
[Proc Natl Acad Sci U S A. 2006]Science. 2001 Feb 16; 291(5507):1279-84.
[Science. 2001]Trends Ecol Evol. 2005 Oct; 20(10):545-52.
[Trends Ecol Evol. 2005]Nat Rev Cancer. 2006 Dec; 6(12):924-35.
[Nat Rev Cancer. 2006]Nat Rev Cancer. 2007 Mar; 7(3):213-21.
[Nat Rev Cancer. 2007]Nucleic Acids Res. 2007; 35(6):1859-67.
[Nucleic Acids Res. 2007]Annu Rev Genet. 2005; 39():309-38.
[Annu Rev Genet. 2005]BMC Bioinformatics. 2003 Sep 11; 4():41.
[BMC Bioinformatics. 2003]Nucleic Acids Res. 2007 Jan; 35(Database issue):D358-62.
[Nucleic Acids Res. 2007]BMC Evol Biol. 2003 Jan 6; 3():2.
[BMC Evol Biol. 2003]Nucleic Acids Res. 2007; 35(6):1859-67.
[Nucleic Acids Res. 2007]Nucleic Acids Res. 2005 Jan 1; 33(Database issue):D433-7.
[Nucleic Acids Res. 2005]Nucleic Acids Res. 2004 Jan 1; 32(Database issue):D255-7.
[Nucleic Acids Res. 2004]Nucleic Acids Res. 2006 Jan 1; 34(Database issue):D556-61.
[Nucleic Acids Res. 2006]Bioinformatics. 2005 Dec 15; 21(24):4432-3.
[Bioinformatics. 2005]Nucleic Acids Res. 2007 Jan; 35(Database issue):D358-62.
[Nucleic Acids Res. 2007]Science. 2006 Mar 3; 311(5765):1283-7.
[Science. 2006]Bioinformatics. 2007 Jan 1; 23(1):127-8.
[Bioinformatics. 2007]Science. 2003 Jun 13; 300(5626):1694.
[Science. 2003]Science. 2003 Jun 13; 300(5626):1703-6.
[Science. 2003]BMC Evol Biol. 2003 Jan 6; 3():2.
[BMC Evol Biol. 2003]BMC Evol Biol. 2003 Jan 6; 3():2.
[BMC Evol Biol. 2003]Genome Res. 2002 Jan; 12(1):17-25.
[Genome Res. 2002]Genome Res. 2003 Jul; 13(7):1589-94.
[Genome Res. 2003]Genome Res. 2006 Mar; 16(3):374-82.
[Genome Res. 2006]Genome Biol. 2007; 8(6):R121.
[Genome Biol. 2007]J Mol Biol. 2001 Dec 14; 314(5):1041-52.
[J Mol Biol. 2001]Mutat Res. 2006 Aug 30; 600(1-2):150-64.
[Mutat Res. 2006]Math Biosci. 1990 Jul; 100(2):143-59.
[Math Biosci. 1990]J Theor Biol. 2005 Jun 21; 234(4):487-95.
[J Theor Biol. 2005]Mutat Res. 2004 Dec 21; 568(2):259-73.
[Mutat Res. 2004]Proc Natl Acad Sci U S A. 2007 May 22; 104(21):8685-90.
[Proc Natl Acad Sci U S A. 2007]Nucleic Acids Res. 2007 Jan; 35(Database issue):D630-7.
[Nucleic Acids Res. 2007]Nucleic Acids Res. 2006 Jan 1; 34(Database issue):D442-5.
[Nucleic Acids Res. 2006]Nucleic Acids Res. 2005 Jan 1; 33(Database issue):D476-80.
[Nucleic Acids Res. 2005]Nat Rev Cancer. 2004 Mar; 4(3):177-83.
[Nat Rev Cancer. 2004]Hum Mutat. 2003 Jun; 21(6):577-81.
[Hum Mutat. 2003]Genome Res. 2002 May; 12(5):680-8.
[Genome Res. 2002]Hum Mutat. 2003 Jun; 21(6):577-81.
[Hum Mutat. 2003]Nucleic Acids Res. 2007; 35(6):1859-67.
[Nucleic Acids Res. 2007]Nucleic Acids Res. 2007 Jan; 35(Database issue):D358-62.
[Nucleic Acids Res. 2007]Nucleic Acids Res. 2007; 35(6):1859-67.
[Nucleic Acids Res. 2007]BMC Bioinformatics. 2003 Sep 11; 4():41.
[BMC Bioinformatics. 2003]Nucleic Acids Res. 2007 Jan; 35(Database issue):D358-62.
[Nucleic Acids Res. 2007]Science. 2006 Mar 3; 311(5765):1283-7.
[Science. 2006]Bioinformatics. 2007 Jan 1; 23(1):127-8.
[Bioinformatics. 2007]Science. 2003 Jun 13; 300(5626):1694.
[Science. 2003]Science. 2006 Mar 3; 311(5765):1283-7.
[Science. 2006]Bioinformatics. 2007 Jan 1; 23(1):127-8.
[Bioinformatics. 2007]Science. 2003 Jun 13; 300(5626):1694.
[Science. 2003]Science. 2003 Jun 13; 300(5626):1703-6.
[Science. 2003]Nature. 2001 Nov 22; 414(6862):450-3.
[Nature. 2001]J Mol Biol. 2001 Dec 14; 314(5):1041-52.
[J Mol Biol. 2001]Nucleic Acids Res. 2007; 35(6):1859-67.
[Nucleic Acids Res. 2007]J Clin Invest. 2005 Oct; 115(10):2633-9.
[J Clin Invest. 2005]Cell Death Differ. 2006 Oct; 13(10):1619-30.
[Cell Death Differ. 2006]Nat Rev Immunol. 2003 Sep; 3(9):745-56.
[Nat Rev Immunol. 2003]Genome Res. 2004 Aug; 14(8):1537-47.
[Genome Res. 2004]Mutat Res. 2003 Jun; 543(3):235-49.
[Mutat Res. 2003]Nucleic Acids Res. 2006 Jan 1; 34(Database issue):D442-5.
[Nucleic Acids Res. 2006]Nucleic Acids Res. 2005 Jan 1; 33(Database issue):D476-80.
[Nucleic Acids Res. 2005]Nucleic Acids Res. 2007 Jan; 35(Database issue):D630-7.
[Nucleic Acids Res. 2007]Nat Rev Cancer. 2004 Mar; 4(3):177-83.
[Nat Rev Cancer. 2004]Nucleic Acids Res. 2006 Jan 1; 34(Database issue):D442-5.
[Nucleic Acids Res. 2006]Nucleic Acids Res. 2005 Jan 1; 33(Database issue):D476-80.
[Nucleic Acids Res. 2005]Nucleic Acids Res. 2007 Jan; 35(Database issue):D630-7.
[Nucleic Acids Res. 2007]Nat Rev Cancer. 2004 Mar; 4(3):177-83.
[Nat Rev Cancer. 2004]Nucleic Acids Res. 2007 Jan; 35(Database issue):D630-7.
[Nucleic Acids Res. 2007]Proc Natl Acad Sci U S A. 2007 May 22; 104(21):8685-90.
[Proc Natl Acad Sci U S A. 2007]Nat Rev Cancer. 2004 Mar; 4(3):177-83.
[Nat Rev Cancer. 2004]Nat Med. 2004 Aug; 10(8):789-99.
[Nat Med. 2004]Trends Ecol Evol. 2005 Oct; 20(10):545-52.
[Trends Ecol Evol. 2005]FEBS Lett. 2004 Apr 9; 563(1-3):7-12.
[FEBS Lett. 2004]Genet Mol Res. 2008 Feb 19; 7(1):152-60.
[Genet Mol Res. 2008]Nat Rev Cancer. 2004 Mar; 4(3):177-83.
[Nat Rev Cancer. 2004]Proc Natl Acad Sci U S A. 1964 Feb; 51():226-31.
[Proc Natl Acad Sci U S A. 1964]J Bacteriol. 1968 Oct; 96(4):975-80.
[J Bacteriol. 1968]Proc Natl Acad Sci U S A. 1975 Jun; 72(6):2202-6.
[Proc Natl Acad Sci U S A. 1975]J Bacteriol. 1969 Oct; 100(1):231-9.
[J Bacteriol. 1969]Cell Death Differ. 2002 May; 9(5):505-12.
[Cell Death Differ. 2002]Nucleic Acids Res. 2007; 35(22):7475-84.
[Nucleic Acids Res. 2007]Nat Rev Cancer. 2003 May; 3(5):339-49.
[Nat Rev Cancer. 2003]Nat Rev Mol Cell Biol. 2005 Jan; 6(1):44-55.
[Nat Rev Mol Cell Biol. 2005]Cell Death Differ. 2006 Jun; 13(6):941-50.
[Cell Death Differ. 2006]Nat Rev Genet. 2007 Oct; 8(10):803-13.
[Nat Rev Genet. 2007]Genome Res. 2002 Jun; 12(6):962-8.
[Genome Res. 2002]Trends Genet. 2007 Aug; 23(8):378-81.
[Trends Genet. 2007]Trends Genet. 2007 Aug; 23(8):375-8.
[Trends Genet. 2007]